Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
Klein
Karen Potvin
KP
Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, USA.
Herrington
David M
DM
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002319:Cardiovascular System / Q000187:drug effects; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use*; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; C038345:droloxifene; D020849:Raloxifene Hydrochloride